PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announces the results of its annual general meeting, held today. All proposals put to a vote of Rosetta Genomics stockholders have passed, including the following:
